Which of the following is used in the treatment of Hepatocellular carcinoma ?: (A) Vandetanib, (B) Pazopanib, (C) Sorafenib, (D) Bevacizumab
Answer is C. Sorafenib is a Tyrosine Kinase inhibitor which is the drug of choice for Hepatocellular carcinoma.